expect more from pharmacology
No animal study can predict with certainty how a therapy will perform in human subjects, yet that is what you need them to do. You need to get as much information from them as possible. Due to study design, the models and technologies available, or lack of proper expertise, most preclinical, in-vivo pharmacological studies are not providing as much information as they could be. These missing insights can derail a pipeline. Missed opportunities are not what you should expect from pharmacology CROs. You should expect more.
Now you can.
You can expect more from PharmaLegacy because PharmaLegacy has more: more models, more experience, and more focus. We have over 1,500 validated animal models, including non-human primate models and many humanized rodent models, spanning over 40 different diseases in the fields of cancer, auto-immunity, inflammation and bone. Our staff has an average of 15 – 20 years of pharmacology experience, and most of them have been with PharmaLegacy for more than 5 years.
When you search for a pharmacology CRO, set your expectations high. Contact PharmaLegacy and let’s discuss how we can exceed them.
the tools to excel, and the people to execute.
To ensure you get the answers you need, you can’t have any weak links in your studies. PharmaLegacy’s experienced scientific staff continuously develop and validate new models to ensure that your critical pipeline decisions are made based on accurate and dependable information.
1,500+
Animal Models Available Immediately
40+
Disease Areas
30,000+
Animal Capacity
380,000
Square Feet of Facility Space
INDS supported
Pharmaceutical
companies trust pharmalegacy
There’s a lot on the line.
Let’s PharmaLegacy get the correct answers.
“The study they delivered on a very reasonable budget was top notch […] The model was executed flawlessly.”
See why a top-20 pharmaceutical company trusts PharmaLegacy for their preclinical immuno-oncology trials.